NVCT
Nuvectis Pharma Inc

822
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 04,
Pre-Market

Estimated EPS

-$0.25

Estimated Rev

$0M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.25
--
--
N/A
Q2 '25
-$0.25
-$0.30
-19.21%
MISSED
Q1 '25
-$0.25
-$0.27
-6.30%
MISSED
Q4 '24
-$0.25
--
--
N/A
Q3 '24
-$0.25
-$0.24
4.91%
BEAT

Latest NVCT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.